References
- Koshy E, Mengting L, Kumar H, Jianbo W. Epidemiology, treatment and prevention of herpes zoster: a comprehensive review. Indian J Dermatol Venereol Leprol 2018;84:251–62.
- Haugnes H, Flem E, Wisloff T. Healthcare costs associated with varicella and herpes zoster in Norway. Vaccine 2019;37:3779–84.
- Akiyama N. Herpes zoster infection complicated by motor paralysis. J Dermatol 2000;27:252–7.
- Sprenger De Rover WB, Alazzawi S, Hallam PJ, Hutchinson R, Di Mascio L. Herpes zoster virus: an unusual but potentially treatable cause of sciatica and foot drop. Orthopedics 2011;34:965–8.
- Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 1988;17:221–31.
- Anadure R, Narayanan C, Varadraj G, Nandeesh B. ANCA associated mononeuritis multiplex with overlap in vasculitic syndromes. J Clin Diagn Res 2017;11:OD01–OD3.
- Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007;44(Suppl 1):S1–26.
- Cunningham AL, Heineman T. Vaccine profile of herpes zoster (HZ/su) subunit vaccine. Expert Rev Vaccines 2017;16:1–10.
- Wang L, Verschuuren EAM, van Leer-buter CC, Bakker SJL, de Joode AAE, Westra J, et al. Herpes zoster and immunogenicity and safety of zoster vaccines in transplant patients: a narrative review of the literature. Front Immunol 2018;9:1632.
- van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2011;70:414–22.